General Information of Drug Off-Target (DOT) (ID: OTU5QWFH)

DOT Name Complexin-2 (CPLX2)
Synonyms Complexin II; CPX II; Synaphin-1
Gene Name CPLX2
Related Disease
Attention deficit hyperactivity disorder ( )
Alzheimer disease ( )
Bipolar depression ( )
Bipolar disorder ( )
Depression ( )
Early-onset non-syndromic cataract ( )
Huntington disease ( )
Myocardial infarction ( )
Nervous system disease ( )
Psychotic disorder ( )
Schizoaffective disorder ( )
Schizophrenia ( )
UniProt ID
CPLX2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF05835
Sequence
MDFVMKQALGGATKDMGKMLGGEEEKDPDAQKKEEERQEALRQQEEERKAKHARMEAERE
KVRQQIRDKYGLKKKEEKEAEEKAALEQPCEGSLTRPKKAIPAGCGDEEEEEEESILDTV
LKYLPGPLQDMFKK
Function
Negatively regulates the formation of synaptic vesicle clustering at active zone to the presynaptic membrane in postmitotic neurons. Positively regulates a late step in exocytosis of various cytoplasmic vesicles, such as synaptic vesicles and other secretory vesicles. Also involved in mast cell exocytosis.
Tissue Specificity
Nervous system. In hippocampus and cerebellum, expressed mainly by excitatory neurons. Down-regulated in brain cortex from patients suffering from Huntington disease, bipolar disorder or major depression. Down-regulated in cerebellum from patients with schizophrenia.
KEGG Pathway
Sy.ptic vesicle cycle (hsa04721 )

Molecular Interaction Atlas (MIA) of This DOT

12 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Attention deficit hyperactivity disorder DISL8MX9 Definitive Genetic Variation [1]
Alzheimer disease DISF8S70 Strong Altered Expression [2]
Bipolar depression DISA75FU Strong Biomarker [3]
Bipolar disorder DISAM7J2 Strong Biomarker [3]
Depression DIS3XJ69 Strong Altered Expression [4]
Early-onset non-syndromic cataract DIS4VPS0 Strong Genetic Variation [5]
Huntington disease DISQPLA4 Strong Biomarker [4]
Myocardial infarction DIS655KI Strong Genetic Variation [6]
Nervous system disease DISJ7GGT Strong Biomarker [4]
Psychotic disorder DIS4UQOT Strong Biomarker [3]
Schizoaffective disorder DISLBW6B Strong Biomarker [3]
Schizophrenia DISSRV2N Strong Genetic Variation [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Complexin-2 (CPLX2). [8]
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of Complexin-2 (CPLX2). [10]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Complexin-2 (CPLX2). [15]
------------------------------------------------------------------------------------
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Complexin-2 (CPLX2). [9]
Testosterone DM7HUNW Approved Testosterone decreases the expression of Complexin-2 (CPLX2). [11]
Ethanol DMDRQZU Approved Ethanol decreases the expression of Complexin-2 (CPLX2). [12]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Complexin-2 (CPLX2). [13]
Amiodarone DMUTEX3 Phase 2/3 Trial Amiodarone increases the expression of Complexin-2 (CPLX2). [14]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Complexin-2 (CPLX2). [16]
Bisphenol A DM2ZLD7 Investigative Bisphenol A affects the expression of Complexin-2 (CPLX2). [17]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

References

1 Genome-wide association study of inattention and hyperactivity-impulsivity measured as quantitative traits.Twin Res Hum Genet. 2013 Apr;16(2):560-74. doi: 10.1017/thg.2013.12.
2 The Proteome of the Dentate Terminal Zone of the Perforant Path Indicates Presynaptic Impairment in Alzheimer Disease.Mol Cell Proteomics. 2020 Jan;19(1):128-141. doi: 10.1074/mcp.RA119.001737. Epub 2019 Nov 7.
3 Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium.Mol Psychiatry. 2004 Jun;9(6):609-20, 544. doi: 10.1038/sj.mp.4001471.
4 Clorgyline-mediated reversal of neurological deficits in a Complexin 2 knockout mouse.Hum Mol Genet. 2010 Sep 1;19(17):3402-12. doi: 10.1093/hmg/ddq252. Epub 2010 Jun 28.
5 Meta-analysis of genome-wide association studies in multiethnic Asians identifies two loci for age-related nuclear cataract.Hum Mol Genet. 2014 Nov 15;23(22):6119-28. doi: 10.1093/hmg/ddu315. Epub 2014 Jun 20.
6 Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations.Atherosclerosis. 2011 Mar;215(1):145-52. doi: 10.1016/j.atherosclerosis.2010.12.005. Epub 2010 Dec 15.
7 Complexin2 modulates working memory-related neural activity in patients with schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2015 Mar;265(2):137-45. doi: 10.1007/s00406-014-0550-4. Epub 2014 Oct 9.
8 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
9 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
10 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
11 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
12 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
13 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
14 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
15 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
16 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
17 Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. Environ Res. 2019 Jun;173:124-134. doi: 10.1016/j.envres.2019.03.035. Epub 2019 Mar 18.